Innate Pharma SA (IPHA) — Institutional Holders, Q2 2026
10 institutional investment managers reported a IPHA position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $354.0K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
IPHA in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- SmartHarvest PortfoliosNew · +23,750 sh+$43.7K
- XTX Topco LtdNew · +15,130 sh+$27.8K
- CITADEL ADVISORSNew · +12,441 sh+$22.9K
- UBS Group AGAdded · +502 sh+$924.00
- Farther Finance AdvisorsAdded · +11 sh+$20.00
Biggest sellers
- JANE STREET GROUPTrimmed · -33,055 sh-$60.8K
- MILLENNIUM MANAGEMENTSold out · -10,064 sh-$18.5K
- GAMMA InvestingTrimmed · -231 sh-$425.00
- RHUMBLINE ADVISERSTrimmed · -15 sh-$28.00
- Caitong International Asset Management , LtdSold out · -2 sh-$4.00
IPHA 13F holders ranked 1–10 of 10
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Lion Point Capital#1 · 81,151 sh | 81,151 | $149.3K | 0.71% | 0.0% |
| 2 | MORGAN STANLEY#2 · 43,524 sh | 43,524 | $80.1K | 0.00% | 0.0% |
| 3 | SmartHarvest Portfolios#3 · 23,750 sh | 23,750 | $43.7K | — | New |
| 4 | XTX Topco Ltd#4 · 15,130 sh | 15,130 | $27.8K | <0.01% | New |
| 5 | CITADEL ADVISORS#5 · 12,441 sh | 12,441 | $22.9K | 0.00% | New |
| 6 | JANE STREET GROUP#6 · 10,310 sh | 10,310 | $19.0K | 0.00% | -76.2% |
| 7 | RHUMBLINE ADVISERS#7 · 4,719 sh | 4,719 | $8.7K | 0.00% | -0.3% |
| 8 | UBS Group AG#8 · 1,363 sh | 1,363 | $2.5K | 0.00% | +58.3% |
| 9 | Farther Finance Advisors#9 · 21 sh | 21 | $38.00 | — | +110.0% |
| 10 | GAMMA Investing#10 · 9 sh | 9 | $17.00 | — | -96.2% |
Funds that sold out of IPHA in Q2 2026 (2)
Held IPHA at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| MILLENNIUM MANAGEMENT10,064 sh | 10,064 | $12.9K |
| Caitong International Asset Management , Ltd2 sh | 2 | $3.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.